Insider · CIK 0001636642

Donley Matthew Maxwell

Reports to the SEC for 2 companies · EDMONTON, A0

sec.gov

Transactions

Companies

Filings

CIK

0001636642

Forms 4 and 5

Insider transactions

42 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-02	AUPHAurinia Pharmaceuticals Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−40.8K sh	$14.21	−$579K	680,299
2026-02-27	AUPHAurinia Pharmaceuticals Inc. · Employee Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+97.3K sh	—	—	97,256
2026-02-27	AUPHAurinia Pharmaceuticals Inc.A Award	Chief Operating Officer	AAward	+58.2K sh	—	—	721,060
2026-02-20	AUPHAurinia Pharmaceuticals Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−32.9K sh	$14.40	−$474K	662,900
2026-01-02	AUPHAurinia Pharmaceuticals Inc.A Award	Chief Operating Officer	AAward	+54.2K sh	—	—	734,631
2026-01-02	AUPHAurinia Pharmaceuticals Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−42.8K sh	$15.95	−$682K	695,801
2025-03-04	AUPHAurinia Pharmaceuticals Inc.S Sale	Chief Operating Officer	SSale	−59K sh	$7.92	−$467K	680,465
2025-03-03	AUPHAurinia Pharmaceuticals Inc.A Award	Chief Operating Officer	AAward	+136K sh	—	—	805,358
2025-03-03	AUPHAurinia Pharmaceuticals Inc.S Sale	Chief Operating Officer	SSale	−65.9K sh	$8.00	−$527K	739,456
2025-02-28	AUPHAurinia Pharmaceuticals Inc. · Employee Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+126K sh	—	—	126,416
2025-02-28	AUPHAurinia Pharmaceuticals Inc.A Award	Chief Operating Officer	AAward	+82.8K sh	—	—	669,791
2024-03-06	AUPHAurinia Pharmaceuticals Inc.S Sale	Chief Operating Officer	SSale	−40.7K sh	$5.51	−$224K	584,072
2024-02-20	AUPHAurinia Pharmaceuticals Inc.A Award	Chief Operating Officer	AAward	+217K sh	—	—	624,737
2023-03-02	AUPHAurinia Pharmaceuticals Inc.A Award	Chief Operating Officer	AAward	+271K sh	—	—	403,141
2022-11-21	AUPHAurinia Pharmaceuticals Inc.P Purchase	Chief Operating Officer	PPurchase	+10K sh	$4.66	+$46.6K	27,927
2022-03-02	AUPHAurinia Pharmaceuticals Inc.A Award	Chief Operating Officer	AAward	+8,500 sh	—	—	19,276
2022-03-02	AUPHAurinia Pharmaceuticals Inc.S Sale	Chief Operating Officer	SSale	−3,052 sh	$12.01	−$36.7K	16,224
2022-03-02	AUPHAurinia Pharmaceuticals Inc. · Restricted Stock UnitA Award	Chief Operating Officer	AAward	+104K sh	—	—	104,080
2022-03-02	AUPHAurinia Pharmaceuticals Inc. · Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+178K sh	—	—	178,063
2021-05-11	AUPHAurinia Pharmaceuticals Inc.P Purchase	Chief Operating Officer	PPurchase	+9,900 sh	$10.07	+$99.7K	9,900
2018-02-13	Sucampo Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	EVP, Global HR, IT & Strategy	DDisposition to Issuer	−75K sh	$4.20	−$315K	0
2018-02-13	Sucampo Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	EVP, Global HR, IT & Strategy	DDisposition to Issuer	−25K sh	$11.25	−$281K	0
2018-02-13	Sucampo Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	EVP, Global HR, IT & Strategy	DDisposition to Issuer	−28K sh	$3.18	−$89K	0
2018-02-13	Sucampo Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	EVP, Global HR, IT & Strategy	DDisposition to Issuer	−101K sh	$6.15	−$621K	0
2018-02-13	Sucampo Pharmaceuticals, Inc.A Award	EVP, Global HR, IT & Strategy	AAward	−37K sh	$18.00	−$666K	36,975
2018-02-13	Sucampo Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	EVP, Global HR, IT & Strategy	DDisposition to Issuer	−150K sh	$10.60	−$1.59M	0
2017-12-31	Sucampo Pharmaceuticals, Inc.A Award	EVP, Global HR, IT & Strategy	AAward	+330 sh	$9.10	+$3,003	36,975
2017-12-28	Sucampo Pharmaceuticals, Inc.F Tax Payment	EVP, Global HR, IT & Strategy	FTax Payment	−19.4K sh	$17.98	−$348K	36,645
2017-09-30	Sucampo Pharmaceuticals, Inc.A Award	EVP, Global HR, IT & Strategy	AAward	+330 sh	$9.10	+$3,003	2,998
2017-06-30	Sucampo Pharmaceuticals, Inc.A Award	EVP, Global HR, IT & Strategy	AAward	+336 sh	$8.93	+$3,000.48	2,668
2017-03-31	Sucampo Pharmaceuticals, Inc.A Award	EVP, Global HR, IT & Strategy	AAward	+321 sh	$9.35	+$3,001.35	2,332
2017-03-06	Sucampo Pharmaceuticals, Inc.Employee Stock Option (right to buy)A Award	EVP, Global HR, IT & Strategy	AAward	+101K sh	—	—	379,000
2017-03-06	Sucampo Pharmaceuticals, Inc.A Award	EVP, Global HR, IT & Strategy	AAward	+53K sh	—	—	53,000
2016-12-31	Sucampo Pharmaceuticals, Inc.A Award	EVP, Global HR, IT & Strategy	AAward	+286 sh	$10.46	+$2,991.56	2,011
2016-09-30	Sucampo Pharmaceuticals, Inc.A Award	EVP, Global HR, IT & Strategy	AAward	+320 sh	$9.38	+$3,001.6	1,725
2016-03-31	Sucampo Pharmaceuticals, Inc.A Award	EVP, Global HR, IT & Strategy	AAward	+376 sh	$9.32	+$3,504.32	1,405
2016-03-31	Sucampo Pharmaceuticals, Inc.A Award	EVP, Global HR, IT & Strategy	AAward	+323 sh	$9.29	+$3,000.67	1,029
2016-03-02	Sucampo Pharmaceuticals, Inc.Employee Stock Option (right to buy)A Award	EVP, Global HR, IT & Strategy	AAward	+75K sh	—	—	278,000
2015-12-31	Sucampo Pharmaceuticals, Inc.A Award	EVP, Global HR, IT & Strategy	AAward	+238 sh	$14.70	+$3,498.6	706
2015-09-30	Sucampo Pharmaceuticals, Inc.A Award	EVP, Global HR, IT & Strategy	AAward	+207 sh	$14.52	+$3,005.64	468
2015-06-30	Sucampo Pharmaceuticals, Inc.A Award	EVP, Global HR, IT & Strategy	AAward	+261 sh	$13.37	+$3,489.57	261
2015-03-04	Sucampo Pharmaceuticals, Inc.Employee Stock Option (right to buy)A Award	EVP, Global HR, IT & Strategy	AAward	+28K sh	—	—	203,000

Recent filings

Accepted (ET)
Mar 34
Donley Matthew Maxwell0001600620-26-000022
SEC(opens sec.gov)
Feb 234
Donley Matthew Maxwell0001636642-26-000002
SEC(opens sec.gov)
Jan 54
Donley Matthew Maxwell0001600620-26-000004
SEC(opens sec.gov)
Mar 44
Donley Matthew Maxwell0001600620-25-000018
SEC(opens sec.gov)
Mar 74
Donley Matthew Maxwell0001600620-24-000036
SEC(opens sec.gov)
Feb 224
Donley Matthew Maxwell0001600620-24-000020
SEC(opens sec.gov)
Mar 64
Donley Matthew Maxwell0001628280-23-006532
SEC(opens sec.gov)
Nov 234
Donley Matthew Maxwell0001628280-22-030745
SEC(opens sec.gov)
Mar 44
Donley Matthew Maxwell0001628280-22-005129
SEC(opens sec.gov)
May 124
Donley Matthew Maxwell0001628280-21-010023
SEC(opens sec.gov)

Companies

Address

#140, 14315-118 AVENUE

EDMONTON, A0, T5L 4S6